Scott Bizily 4 D Molecular Therapeutics, Inc. (FDMT) insider trading activity

Scott Bizily is Chief Legal Officer of 4D Molecular Therapeutics, Inc.. Currently has a direct ownership of 6,781 shares of FDMT, which is worth approximately $37,634. The most recent transaction as insider was on Sep 16, 2024, when has been sold 500 shares (Common Stock) at a price of $16.33 per share, resulting in proceeds of $8,164. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.78K

0% 3M change

290.39% 12M change

Total Value Held $37,634

Scott Bizily Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 16 2024	SELL Open market or private sale	$8,164 $16.33 p/Share	500 Reduced 6.87%	6,781 Common Stock
Sep 16 2024	BUY Exercise of conversion of derivative security	$3,245 $6.49 p/Share	500 Added 6.43%	7,281 Common Stock
Aug 19 2024	SELL Open market or private sale	$7,500 $15.0 p/Share	500 Reduced 6.87%	6,781 Common Stock
Aug 19 2024	BUY Exercise of conversion of derivative security	$3,245 $6.49 p/Share	500 Added 6.43%	7,281 Common Stock
Jul 16 2024	SELL Open market or private sale	$47,442 $27.11 p/Share	1,750 Reduced 20.51%	6,781 Common Stock
Jul 16 2024	BUY Exercise of conversion of derivative security	$12,722 $7.27 p/Share	1,750 Added 17.02%	8,531 Common Stock
Jul 11 2024	SELL Open market or private sale	$49,900 $25.0 p/Share	1,996 Reduced 22.74%	6,781 Common Stock
Jul 11 2024	BUY Exercise of conversion of derivative security	$31,496 $15.78 p/Share	1,996 Added 18.53%	8,777 Common Stock
Jul 01 2024	SELL Open market or private sale	$90,737 $21.36 p/Share	4,248 Reduced 70.98%	1,737 Common Stock
Jul 01 2024	BUY Exercise of conversion of derivative security	$30,882 $7.27 p/Share	4,248 Added 41.51%	5,985 Common Stock
Jun 17 2024	SELL Open market or private sale	$41,492 $23.71 p/Share	1,750 Reduced 50.19%	1,737 Common Stock
Jun 17 2024	BUY Exercise of conversion of derivative security	$12,722 $7.27 p/Share	1,750 Added 33.42%	3,487 Common Stock
May 16 2024	SELL Open market or private sale	$44,712 $25.55 p/Share	1,750 Reduced 50.19%	1,737 Common Stock
May 16 2024	BUY Exercise of conversion of derivative security	$12,722 $7.27 p/Share	1,750 Added 33.42%	3,487 Common Stock
Apr 16 2024	SELL Open market or private sale	$45,045 $25.74 p/Share	1,750 Reduced 50.19%	1,737 Common Stock
Apr 16 2024	BUY Exercise of conversion of derivative security	$12,722 $7.27 p/Share	1,750 Added 33.42%	3,487 Common Stock
Apr 01 2024	SELL Open market or private sale	$259,102 $31.78 p/Share	8,153 Reduced 82.44%	1,737 Common Stock
Apr 01 2024	BUY Exercise of conversion of derivative security	$103,053 $12.64 p/Share	8,153 Added 45.19%	9,890 Common Stock
Mar 27 2024	SELL Open market or private sale	$204,388 $35.04 p/Share	5,833 Reduced 77.05%	1,737 Common Stock
Mar 27 2024	BUY Exercise of conversion of derivative security	$151,541 $25.98 p/Share	5,833 Added 43.52%	7,570 Common Stock
Mar 18 2024	SELL Open market or private sale	$54,722 $31.27 p/Share	1,750 Reduced 50.19%	1,737 Common Stock
Mar 18 2024	BUY Exercise of conversion of derivative security	$12,722 $7.27 p/Share	1,750 Added 33.42%	3,487 Common Stock
Feb 27 2024	SELL Open market or private sale	$57,270 $30.0 p/Share	1,909 Reduced 52.36%	1,737 Common Stock
Feb 27 2024	BUY Exercise of conversion of derivative security	$38,638 $20.24 p/Share	1,909 Added 34.37%	3,646 Common Stock
Feb 16 2024	SELL Open market or private sale	$48,422 $27.67 p/Share	1,750 Reduced 50.19%	1,737 Common Stock

Scott Bizily

Chief Legal Officer

Emeryville, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FDMT shares.

Notify only if

Value

Insider Trading

Get notified when an 4 D Molecular Therapeutics, Inc. insider buys or sells FDMT shares.

Notify only if

Operation

Value

Type

News

Receive news related to 4D Molecular Therapeutics, Inc.

Track Activities on FDMT

Account